PhaseBio Pharmaceuticals (PHAS) Insider Trading & Ownership Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSustainabilityTrendsStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSustainabilityTrends PhaseBio Pharmaceuticals (NASDAQ:PHAS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.90%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$30,000.00Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$290,167.69 Get PHAS Insider Trade Alerts Want to know when executives and insiders are buying or selling PhaseBio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PHAS Insider Buying and Selling by Quarter Ad Stansberry ResearchGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."Click here now to watch this exclusive interview PhaseBio Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/25/2022Enterprise Associates 13 L NewMajor ShareholderSell1,784,109$0.15$267,616.35 5/23/2022Glen BurkhardtSVPSell11,248$0.79$8,885.92 11/19/2021Glen BurkhardtVPSell5,766$2.37$13,665.42 8/18/2021Clay ThorpDirectorBuy10,000$3.00$30,000.00 (Data available from 1/1/2013 forward) PHAS Insider Trading Activity - Frequently Asked Questions Who is on PhaseBio Pharmaceuticals's Insider Roster? The list of insiders at PhaseBio Pharmaceuticals includes Clay Thorp, Enterprise Associates 13 L New, and Glen Burkhardt. Learn more on insiders at PHAS. What percentage of PhaseBio Pharmaceuticals stock is owned by insiders? 9.90% of PhaseBio Pharmaceuticals stock is owned by insiders. Learn more on PHAS's insider holdings. Which PhaseBio Pharmaceuticals insiders have been selling company stock? The following insider sold PHAS shares in the last 24 months: Enterprise Associates 13 L New ($267,616.35). How much insider selling is happening at PhaseBio Pharmaceuticals? Insiders have sold a total of 1,784,109 PhaseBio Pharmaceuticals shares in the last 24 months for a total of $267,616.35 sold. More Insider Trading Tools from MarketBeat Related Companies: Kintara Therapeutics Insider Ownership Kiora Pharmaceuticals Insider Ownership Avalo Therapeutics Insider Ownership Vaxxinity Insider Ownership Chemomab Therapeutics Insider Ownership Guardion Health Sciences Insider Ownership Lumos Pharma Insider Ownership Monopar Therapeutics Insider Ownership Eterna Therapeutics Insider Ownership Vaccinex Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Selling: When It Matters and When It Doesn'tInsiders Sell These Tech Stocks, but Investors Shouldn’tWhat Does Market Rotation Mean for This Top AI Stock?3 Beaten Down Stocks That Insiders Are Buying3 Insider-Buy Stocks to Add to Your Watchlist Now This page (NASDAQ:PHAS) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PhaseBio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PhaseBio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.